Studi clinici su BPCO a Dallas, TX
12 studi su BPCO cercano partecipanti presso sedi a Dallas e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
In reclutamentoFase 3
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
In reclutamentoFase 3
- IntraCare- Site Number : 8400034, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
In reclutamentoFase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
In reclutamento
- University of Texas Southwestern, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
In reclutamentoFase 2
- Research Site, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
In reclutamentoFase 3
- Research Site, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
In reclutamentoFase 2/3
- Alina Clinical Trials, LLC., Dallas
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
In reclutamentoFase 3
- GC2501 Study Site 109, Dallas
STRIVE Post-Market Registry Study
In reclutamentoStudio osservazionale
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
In reclutamentoFase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
In reclutamentoStudio osservazionale
- Liver Center of Texas, Dallas
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
In reclutamentoFase 3
- GSK Investigational Site, Dallas
Studi su BPCO in altre città
- Philadelphia, PA23 studi
- Miami, FL18 studi
- Birmingham, AL17 studi
- Boston, MA17 studi
- Orlando, FL15 studi
- Houston, TX15 studi
- Baltimore, MD14 studi
- Chicago, IL14 studi
- Pittsburgh, PA12 studi
- New York City, NY11 studi
- Ann Arbor, MI10 studi
- Detroit, MI9 studi
Altri studi a Dallas
- Cancro al seno55 studi
- Cancro del polmone non a piccole cellule52 studi
- Cancro metastatico42 studi
- Insufficienza cardiaca42 studi
- Cancro (tutti i tipi)37 studi
- Cancro alla prostata36 studi
- Cancro colorettale33 studi
- Obesità30 studi
- Cancro ovarico28 studi
- Cancro della vescica27 studi
- Cancro ai polmoni27 studi
- Cancro dell'endometrio24 studi
Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.